NC
Neurocompute
AI-powered research intelligence
 Partner With Us →
Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,316 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

Explore Platform → See latest papers
40,316 Papers indexed
1,440 Papers AI scored
40,316 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.
LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-11 10:15 AM
1 Sensitive LC-MS/MS Method for Simultaneous Quantification of Alectinib and Its Major Metabolite M4 in Limited-Volume Human Plasma. Biomedical chromatography : BMC — Nov 11, 2026 2 Patient reimbursement in therapeutic cancer clinical trials: An 18-year multicenter experience. Cancer — Nov 11, 2026 3 Adulthood risk of non-communicable diseases associated with childhood and adolescent malnutrition in low- and middle-income countries: a systematic review of observational studies. BMJ global health — Nov 11, 2026 4 Parental night shift work and risk of breast cancer in daughters. Environmental research — Nov 11, 2026 5 Influence of diaphragm structure and function on the exercise ventilatory response in childhood cancer survivors and non-cancer controls. Respiratory medicine — Nov 11, 2026 6 Pregnancy and classic Hodgkin lymphoma: real world outcomes from a single center in Egypt. Current problems in cancer — Nov 11, 2026 7 Racial and Ethnic Differences in the Incidence of Langerhans Cell Histiocytosis Across the Age Spectrum. Blood advances — Nov 11, 2026 8 International Cross-Age Consensus Guideline on Measurable Residual Disease Assessment in Acute Lymphoblastic Leukemia. Blood — Nov 11, 2026
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40316 results
D
Prophylactic heminephrectomy for an asymptomatic, non-functioning moiety in pediatric duplex systems: is cancer prevention justified?
PMID 41488907 Published: 2025-12-18 Ingested: 2026-08-02 12:03 AM Frontiers in pediatrics
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Hypertension in Pediatric Acute Lymphoblastic Leukemia (ALL).
PMID 41483400 Published: 2026-01-02 Ingested: 2026-08-02 12:06 AM Indian journal of pediatrics
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Melanocytoma With Morphologic Features Reminiscent of BAP-1-Inactivated Melanocytoma but With a Different Molecular Profile.
PMID 41481331 Published: 2026-01-02 Ingested: 2026-08-02 12:06 AM The American Journal of dermatopathology
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Letter to the Editor re: "Urothelial cell carcinoma of the bladder in pediatric patients: A comparison with adults from the National Cancer Database".
PMID 41475955 Published: 2025-12-15 Ingested: 2026-08-02 12:05 AM Journal of pediatric urology
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Combined Transcranial-Orbital Approach for Resection of a Pediatric Optic Nerve Glioma With Preservation of the Annulus of Zinn: 2-Dimensional Operative Video.
PMID 41460689 Published: 2025-12-29 Ingested: 2026-08-02 12:05 AM Operative neurosurgery (Hagerstown, Md.)
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Novel Glomeruloid Adenocarcinoma Arising in the Mandible Harboring EWSR1::YY1.
PMID 41460425 Published: 2025-12-29 Ingested: 2026-08-02 12:05 AM Head and neck pathology
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.

D
Severe Vitamin D Deficiency Mimicking Bone Tumor in an Adolescent: Authors' Reply.
PMID 41452435 Published: 2025-12-26 Ingested: 2026-08-02 12:05 AM Indian journal of pediatrics
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Editorial: Immunological therapies in pediatric cancers: a Latin American perspective.
PMID 41450921 Published: 2025-12-10 Ingested: 2026-08-02 12:03 AM Frontiers in oncology
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

D
Scratching the surface of targeting GPC2 on pediatric CNS tumors.
PMID 41438131 Published: 2025-12-04 Ingested: 2026-08-02 12:05 AM Molecular therapy. Oncology
AI -
Standard 47.5
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 47.5/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 100.0; abstract quality: 0.0.

Previous
Page 3058 of 3360
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.
Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic